Symptoma
European health and IT company aimed at matching clients to their correct diagnoses.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
N/A | Grant | ||
| Total Funding | 000k | ||
| USD | 2019 | 2020 | 2021 | 2023 |
|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 97 % | 30 % | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Symptoma is a digital health company specializing in an AI-driven symptom checker that assists both patients and medical professionals in diagnosing potential medical conditions. Operating in the digital health market, Symptoma's platform allows users to input symptoms and receive a list of probable causes, ranked by likelihood. This service is particularly valuable for identifying even rare diseases, leveraging 17 years of scientific research and data analysis. The platform is widely used, boasting millions of users and searches each month. Symptoma generates revenue through a freemium model, offering basic services for free while charging for advanced features and professional use. The company also holds a CE mark as a medical device, ensuring compliance with European health standards. Key clients include individual patients seeking initial diagnoses and healthcare providers looking for diagnostic support.
Keywords: AI, symptom checker, digital health, medical diagnostics, rare diseases, freemium model, healthcare, CE mark, scientific research, data analysis.